Cargando…

An Atypical Case of Shiga Toxin Producing-Escherichia Coli Hemolytic and Uremic Syndrome (STEC-HUS) in a Lung Transplant Recipient

We herein describe the first case of thrombotic microangiopathy (TMA) which was related to Shiga toxin producing-Escherichia Coli Hemolytic and Uremic Syndrome (STEC-HUS) after lung transplantation. His maintenance immunosuppression relied on tacrolimus plus mycophenolic acid. TMA was treated with p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manière, Louis, Domenger, Camille, Camara, Boubou, Giovannini, Diane, Malvezzi, Paolo, Rostaing, Lionel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487164/ https://www.ncbi.nlm.nih.gov/pubmed/31110835 http://dx.doi.org/10.1155/2019/9465040

Ejemplares similares

Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS)
por: Loos, Sebastian, et al.
Publicado: (2021)

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
por: Scheiring, Johanna, et al.
Publicado: (2008)

Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
por: Fakhouri, Fadi, et al.
Publicado: (2021)

Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management
por: Yenerel, Mustafa N.
Publicado: (2014)

Comparative Genomics to Delineate Pathogenic Potential in Non-O157 Shiga Toxin-Producing Escherichia coli (STEC) from Patients with and without Haemolytic Uremic Syndrome (HUS) in Norway
por: Haugum, Kjersti, et al.
Publicado: (2014)

Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England
por: Jenkins, Claire, et al.
Publicado: (2020)

Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals
por: Mayer, Chad L., et al.
Publicado: (2012)

Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)
por: Mejías, Maria P., et al.
Publicado: (2016)

Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement
por: Pape, Lars, et al.
Publicado: (2016)

Shiga Toxin–Producing Escherichia coli (STEC)
por: Hunt, John M.
Publicado: (2010)

Shiga Toxin–Associated Hemolytic Uremic Syndrome in Adults, France, 2009–2017
por: Travert, Benoît, et al.
Publicado: (2021)

Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
por: Joseph, Adrien, et al.
Publicado: (2020)

Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome
por: Chang, Hye Jin, et al.
Publicado: (2014)

Relevance of Bacteriophage 933W in the Development of Hemolytic Uremic Syndrome (HUS)
por: Del Cogliano, Manuel E., et al.
Publicado: (2018)

The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin E. coli Mediated HUS
por: Feitz, Wouter J. C., et al.
Publicado: (2021)

Atypical hemolytic uremic syndrome (aHUS) responsive to mycophenolate mofetil: A case report from Nepal
por: Gurung, Jyoti, et al.
Publicado: (2022)

Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm?
por: Bielaszewska, Martina, et al.
Publicado: (2007)

Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome
por: Buelli, Simona, et al.
Publicado: (2019)

New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome
por: Petruzziello-Pellegrini, Tania N, et al.
Publicado: (2013)

Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura
por: Oh, Jisu, et al.
Publicado: (2019)

Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in a renal transplant recipient case report
por: Nieto-Rios, John Fredy, et al.
Publicado: (2020)

Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab
por: Umscheid, Jacob H., et al.
Publicado: (2021)

Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS)
por: Goldwater, Paul N, et al.
Publicado: (2012)

Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report
por: Ohanian, Maro, et al.
Publicado: (2011)

Baseline characteristics and evolution of Brazilian patients with atypical hemolytic uremic syndrome: first report of the Brazilian aHUS Registry
por: Vaisbich, Maria Helena, et al.
Publicado: (2022)

The Role of Escherichia coli Shiga Toxins in STEC Colonization of Cattle
por: Menge, Christian
Publicado: (2020)

Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities
por: McCoy, Nicole, et al.
Publicado: (2014)

Epidemiology and Characterization of Shiga Toxin-Producing Escherichia Coli of Hemolytic Uremic Syndrome in Argentina
por: Torti, Jeronimo F, et al.
Publicado: (2021)

Diagnosis and Treatment for Shiga Toxin-Producing Escherichia coli Associated Hemolytic Uremic Syndrome
por: Liu, Yang, et al.
Publicado: (2022)

Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies
por: Perrier, Quentin, et al.
Publicado: (2021)

Antibiotic resistance and integrons in Shiga toxin-producing Escherichia coli (STEC)
por: Colello, Rocío, et al.
Publicado: (2015)

Advances in detection methods for Shiga toxin-producing Escherichia coli (STEC)
por: Padola, Nora L.
Publicado: (2014)

Application of Bacteriophages on Shiga Toxin-Producing Escherichia coli (STEC) Biofilm
por: Mangieri, Nicola, et al.
Publicado: (2021)

Editorial: Shiga toxin-producing Escherichia coli (STEC) infections and consequences
por: Goldstein, Jorge, et al.
Publicado: (2022)

Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome
por: Álvarez, Romina S., et al.
Publicado: (2021)

Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011)

Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013)

Impact of Shiga-toxin encoding gene transduction from O80:H2 Shiga toxigenic Escherichia coli (STEC) on non-STEC strains
por: Habets, Audrey, et al.
Publicado: (2022)

Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study
por: Bouwmeester, Romy N., et al.
Publicado: (2022)

Fecal diagnostics in combination with serology: best test to establish STEC-HUS
por: Wijnsma, Kioa L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uru11jevrtorogap65kio9v5hn